A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with

Amit G Singal1, Michael L Volk, Donald Jensen

  • 1Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, Michigan, USA.

Insights

Achieving sustained viral response (SVR) significantly reduces liver-related mortality, hepatocellular carcinoma (HCC), and decompensated cirrhosis in hepatitis C virus (HCV) patients. Patients failing treatment face substantial risks without SVR.

Area of Science:

  • Hepatology
  • Viral Hepatitis Research
  • Clinical Outcomes Research

Background:

  • Hepatitis C virus (HCV) infection can lead to severe liver complications.
  • The long-term outcomes for HCV patients achieving sustained viral response (SVR) versus treatment failure are not fully understood.
  • Key outcomes of concern include decompensated cirrhosis, hepatocellular carcinoma (HCC), and liver-related mortality.

Purpose of the Study:

  • To quantify the incidences of decompensated cirrhosis, HCC, and liver-related mortality in HCV patients.
  • To compare these outcomes between patients who achieve SVR and those who experience treatment failure.
  • To analyze outcomes specifically in HCV patients with advanced fibrosis.

Main Methods:

  • A meta-analysis of observational cohort studies was conducted.
  • Studies included HCV patients who failed treatment, with data stratified by SVR status.
  • Data extraction was performed by two independent investigators with over 95% agreement.

Main Results:

  • The meta-analysis included 26 studies.
  • Among HCV patients with advanced fibrosis who failed treatment, significant annual rates of liver-related mortality (2.73%), HCC (3.22%), and hepatic decompensation (2.92%) were observed.
  • Patients achieving SVR had significantly lower risks of liver-related mortality (RR 0.23), HCC (RR 0.21), and hepatic decompensation (RR 0.16) compared to treatment failure patients.

Conclusions:

  • HCV patients with advanced fibrosis who do not achieve SVR face substantial liver-related morbidity and mortality.
  • Achieving SVR dramatically lowers the risk of severe liver complications and death in HCV patients.
  • SVR is a critical determinant of improved long-term outcomes for hepatitis C patients.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...